¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"models, molecular"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • molecular genetic study
    ºÐÀÚÀ¯ÀüÇа˻ç
  • molecular genetics
    ºÐÀÚÀ¯ÀüÇÐ
  • molecular grating
    ºÐÀÚ°ÝÀÚ
  • molecular heat
    ºÐÀÚ¿­
  • molecular layer
    ºÐÀÚÃþ
  • molecular magnet
    ºÐÀÚÀÚ¼®
  • molecular marker
    ºÐÀÚÇ¥ÁöÀÚ
  • molecular mimicry
    ºÐÀÚ¸ð¹æ
  • molecular neurobiology
    ºÐÀڽŰæ»ý¹°ÇÐ
  • molecular orientation
    ºÐÀÚ¹èÇâ
  • molecular physiology
    ºÐÀÚ»ý¸®ÇÐ
  • molecular radiation biology
    ºÐÀÚ¹æ»ç¼±»ý¹°ÇÐ
  • molecular refraction
    ºÐÀÚ±¼Àý
  • molecular sieve
    ºÐÀÚü
  • molecular tumbling rate
    ºÐÀÚÅÒºí¸µ·ü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • molecular grating
    ºÐÀÚ°ÝÀÚ
  • molecular check point gene
    ºÐÀڰ˹®À¯ÀüÀÚ
  • molecular heat
    ºÐÀÚ¿­
  • molecular hypothesis
    ºÐÀÚ°¡¼³
  • molecular layer
    ºÐÀÚÃþ
  • molecular
    ºÐÀÚ-
  • molecular magnet
    ºÐÀÚÀÚ¼®
  • molecular marker
    ºÐÀÚÇ¥ÁöÀÚ
  • molecular mimicry
    ºÐÀÚ¸ð¹æ
  • molecular neurobiology
    ºÐÀڽŰæ»ý¹°ÇÐ
  • molecular orientation
    ºÐÀÚ¹èÇâ
  • molecular physiology
    ºÐÀÚ»ý¸®ÇÐ
  • molecular refraction
    ºÐÀÚ±¼Àý
  • molecular sieve
    ºÐÀÚü
  • molecular spectrum
    ºÐÀÚ½ºÆåÆ®·³
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • molecular clock
    ºÐÀÚ»ý¹°ÇÐÀû ½Ã°è
  • molecular colloid
    ºÐÀÚ(ÝÂí­)ÄÝ·ÎÀ̵å.
  • molecular compound
    ºÐÀÚÈ­ÇÕ¹°(ÝÂí­ ûùùêÚª).
  • molecular conductivity
    ¸ôÀüµµÀ² (¡­îîÓôëÒ).
  • molecular death
    ºÐÀÚ»ç(ÝÂí­ÞÝ).
  • molecular depression
    ºÐÀÚ°­ÇÏ(¡­Ë½ù»).
  • molecular disease
    ºÐÀÚº´(ÝÂí­Ü»).
  • molecular dispersion
    ºÐÀںлê(¡­ÝÂߤ).
  • molecular distillation
    ºÐÀÚÁõ·ù(¡­ñúë§).
  • molecular elevation
    ºÐÀÚ»ó½Â(¡­ß¾ã°).
  • molecular extinction coefficient
    ºÐÀÚ¼Ò¸ê°è¼ö(¡­á¼ØþÌõâ¦).
  • molecular fat
    ºÐÀÚ¼º Áö¹æ(¡­àõò·Û¸).
  • molecular film
    ºÐÀÚ¸·(ÝÂí­Ø¯).
  • molecular filter
    ºÐÀڰŸ£°³.
  • molecular force
    ºÐÀÚ·Â(ÝÂí­æ³).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • molecular orbital theory
    ºÐÀڱ˵µ¼³(ÝÂí­ÏùÔ³àã)
  • molecular photosensitization
    ºÐÀÚ ±¤°¨ÀÛ(ÝÂí­ÎÃÊõíÂ)
  • molecular radioautography
    ºÐÀÚ ¹æ»ç¼±ÀÚ°¡±â·Ï¹ý(ÝÂí­Û¯ÞÒàÊí»Ê«ÑÀÖâÛö)
  • molecular rotation
    ºÐÀÚȸÀü(ÝÂí­üÞï®)
  • molecular sieve
    ºÐÀÚ(ÝÂí­)ä
  • molecular sieve chromatography
    ºÐÀÚ(ÝÂí­)ä Å©·Î¸¶Åä±×¶óÇÇ
  • molecular sieve coefficient
    ºÐÀÚ(ÝÂí­)ä °è¼ö(Ìõâ¦)
  • molecular surface
    ºÐÀÚÇ¥¸é(ÝÂí­øúØü)
  • molecular taxonomy
    ºÐÀÚ ºÐ·ùÇÐ(ÝÂí­ÝÂ×¾ùÊ)
  • molecular vibration
    ºÐÀÚ Áøµ¿(ÝÂí­òèÔÑ)
  • molecular weight
    ºÐÀÚ·®(ÝÂí­Õá)
  • molecular weight average
    ºÐÀÚ·® Æò±Õ(ÝÂí­ÕáøÁг)
  • neutral theory of molecular evolution
    Á߸³ºÐÀÚÁøÈ­·Ð(ñ騡ÝÂí­òäûùÖå)
  • number-average molecular weight
    ¹«Æò±ÕºÐÀÚ·®(ÙíøÁгÝÂí­Õá)
  • target molecular weight
    Ç¥ÀûºÐÀÚ·® (øöîÜÝÂí­Õá)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
EMBO European Molecular Biology Organization
EMER electromagnetic molecular electron resonance
GMV gram molecular volume
GMW gram molecular weight
HMW high-molecular-weight
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
HMM High molecular mass
HMW High molecular weight
HMWK High molecular weight kininogen
MW High-molecular-weight
HOMO Highest Occupied Molecular Orbital
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • molecular genetics
    ºÐÀÚ À¯ÀüÇÐ
  • molecular heat
    ºÐÀÚ ¿­
  • molecular layer
    ºÐÀÚ Ãþ
  • molecular magnet
    ºÐÀÚ ÀÚ¼®
  • molecular miocrobiology
    ºÐÀÚ ¹Ì»ý¹°ÇÐ
  • molecular orientation
    ºÐÀÚ ¹èÇâ
  • molecular physiology
    ºÐÀÚ »ý¸®ÇÐ
  • molecular rearrangement
    ºÐÀÚ Àç¹è¿­
  • molecular shape
    ºÐÀÚ Çü»ó
  • molecular site
    ºÐÀÚ À§
  • molecular still
    ºÐÀÚ Áõ·ù±â
  • molecular tension
    ºÐÀÚ Àå·Â
  • molecular tumbling
    ºÐÀÚ ÅÒºí¸µ
  • molecular virology
    ºÐÀÚ ¹ÙÀÌ·¯½ºÇÐ
  • molecular weight
    ºÐÀÚ·®
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
models, theoretical Theoretical representations that simulate the behaviour or activity of systems, processes, or phenomena. They include the use of mathematical equations, computers, and other electronic equipment.
(12 Dec 1998)
prevalence models <epidemiology> Prevalence models are compartmental models dividing the host population into, for example, susceptible, latent, infectious and immune individuals.
(05 Dec 1998)
proportional hazards models Statistical models used in survival analysis that assert that the effect of the study factors on the hazard rate in the study population is multiplicative and does not change over time.
(12 Dec 1998)
disease models, animal Animal disease whose pathologic mechanisms are sufficiently similar to those of a different human disease for the animal disease to serve as a model. The animal disease may be either induced or naturally occurring so long as it is not the same clinical entity as the disease for which it serves as a model. E.g., scrapie is an animal model for multiple sclerosis, which has never been found or induced in an animal.
(12 Dec 1998)
transgenic disease models Animals that have been created to acquire particular human diseases.
(14 Nov 1997)
linear models Statistical models in which the value of a parameter for a given value of a factor is assumed to be equal to a + bx, where a and b are constants. The models predict a linear regression.
(12 Dec 1998)
lock and key models <chemistry, immunology> Specific recognition in biological systems might be mediated through interactions that depend upon very precise steric matching between receptor and ligand or between enzyme and substrate. The commonly used analogy is between lock and key and implies a precise sterically determined interaction.
(18 Nov 1997)
logistic models Statistical models which describe the relationship between a qualitative dependent variable (that is, one which can take only certain discrete values, such as the presence or absence of a disease) and an independent variable. A common application is in epidemiology for estimating an individual's risk (probability of a disease) as a function of a given risk factor.
(12 Dec 1998)
relative molecular mass The sum of the atomic weight's of all the atoms constituting a molecule; the mass of a molecule relative to the mass of a standard atom, now 12C (taken as 12.000). Relative molecular mass (Mr) is the mass relative to the dalton and has no units.
See: atomic weight.
Synonym: molecular mass, molecular weight ratio, relative molecular mass.
(05 Mar 2000)
gram-molecular weight Molecular weight expressed in grams.
Compare: mole.
(05 Mar 2000)
cloning, molecular The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells.
(12 Dec 1998)
molecular <chemistry> Of, pertaining to or composed of molecules: a very small mass of matter.
(18 Nov 1997)
molecular behaviour <psychology> Behaviour described in small response units rather than larger ones; a specific response.
Compare: molar behaviour.
(05 Mar 2000)
molecular biology <study> The study of the biochemistry of cells, it is closely linked to cell biology, in particular the biochemistry of DNA and cogeners.
(16 Dec 1997)
molecular biophysics Biophysics concerned with membrane processes, conformational and configurational properties of macromolecules, bioelectrical phenomena, etc.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á